According to Vitrolife AB's latest financial reports the company's current EPS (TTM) is $0.47. In 2023 the company made an earnings per share (EPS) of -$3.95 a decrease over its 2022 EPS that were of $0.39.
Year | EPS | Change |
---|---|---|
2024 (TTM) | $0.45 | -111.46% |
2023 | -$3.95 | -1109.12% |
2022 | $0.39 | -14.75% |
2021 | $0.46 | 1.83% |
2020 | $0.45 | -14.66% |
2019 | $0.53 | 19.03% |
2018 | $0.44 | 6.83% |
2017 | $0.42 | 53.82% |
2016 | $0.27 | -3.56% |
2015 | $0.28 | 42.16% |
2014 | $0.20 | 58.99% |
2013 | $0.12 | -83.1% |
2012 | $0.73 | 1062.75% |
2011 | $0.06301 | 2.77% |
2010 | $0.06131 | -11.28% |
2009 | $0.06911 | 27.36% |
2008 | $0.05427 | -31.11% |
2007 | $0.07877 | 150.37% |
2006 | $0.03146 | 10.6% |
2005 | $0.02845 | -2.04% |
2004 | $0.02904 | -69.22% |
2003 | $0.09433 | -53.67% |
2002 | $0.20 |